scholarly article | Q13442814 |
P50 | author | Nicola Giordano | Q42773464 |
Alberto Palazzuoli | Q56574372 | ||
P2093 | author name string | Annalisa Santucci | |
Natale Figura | |||
Ranuccio Nuti | |||
Michele Sozzi | |||
Panagiotis Papakostas | |||
Cristina Lenzi | |||
Fabio Rollo | |||
Catia Gonnelli | |||
Giuliano Alegente | |||
Maria-Stella Campagna | |||
P2860 | cites work | Helicobacter pylori and gastric cancer | Q70600355 |
Relationship of immune response to heat-shock protein A and characteristics of Helicobacter pylori-infected patients | Q71735381 | ||
Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development | Q73074082 | ||
Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men | Q73660469 | ||
Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects | Q73741235 | ||
Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection | Q77222223 | ||
The expression of heat shock protein 60 in patients with dilated cardiomyopathy | Q77747713 | ||
Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies | Q78057493 | ||
The heat-shock proteins | Q29617227 | ||
Infection and atherosclerosis: emerging mechanistic paradigms | Q33696699 | ||
Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation | Q35159020 | ||
Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction | Q35567077 | ||
Heat shock proteins and stress in atherosclerosis | Q35862376 | ||
The groES and groEL heat shock gene products of Escherichia coli are essential for bacterial growth at all temperatures | Q36174913 | ||
Helicobacter pylori infection in childhood: risk factors and effect on growth | Q36888795 | ||
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors | Q37047617 | ||
Stress proteins, autoimmunity, and autoimmune disease | Q37765342 | ||
Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty | Q37874031 | ||
Helicobacter pylori hspA-hspB heat-shock gene cluster: nucleotide sequence, expression, putative function and immunogenicity. | Q38302075 | ||
Campylobacter pylori and peptic ulcer disease | Q38596277 | ||
Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin | Q39820932 | ||
The role of heat shock proteins in protection and pathophysiology of the arterial wall | Q41181626 | ||
Relation of Helicobacter pylori infection and coronary heart disease | Q41333642 | ||
The multiple mechanisms by which infection may contribute to atherosclerosis development and course | Q43851339 | ||
Infection by CagA-positive Helicobacter pylori strains in patients with ischemic heart disease: prevalence and association with exercise-induced electrocardiographic abnormalities | Q43980775 | ||
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma | Q44824307 | ||
Association of virulent Helicobacter pylori strains with ischemic heart disease. | Q50887983 | ||
Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. | Q52867890 | ||
P433 | issue | 48 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Helicobacter pylori | Q180556 |
P304 | page(s) | 7815-7820 | |
P577 | publication date | 2006-12-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease | |
P478 | volume | 12 |
Q37772429 | Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis |
Q24201388 | Antibiotics for secondary prevention of coronary heart disease |
Q57389403 | Antibiotics for secondary prevention of coronary heart disease |
Q39312633 | Application of proteomics to the study of Helicobacter pylori and implications for the clinic |
Q36596797 | Association between Bacterial Infection and Peripheral Vascular Disease: A Review |
Q33412165 | Clinical effects of Helicobacter pylori outside the stomach |
Q38211000 | Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence. |
Q33376411 | Extragastric manifestations of Helicobacter pylori infection -- other Helicobacters |
Q33401864 | Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review |
Q51475016 | Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction. |
Q92142495 | Identification of a novel anti‑heat shock cognate 71 kDa protein antibody in patients with Kawasaki disease |
Q83217794 | Serum levels of high-sensitivity C-reactive protein (hs-CRP)in Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor |
Search more.